MapLight Therapeutics, Inc.(MPLT)
Biotechnology
Neuroscience Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-20 | Kreitzer Anatol Chief Discovery Officer | Sale | -36,284 | -17.18%174,906 | $37.09 | $1,345,894 | View SEC filing | |
| 2026-07-20 | GILLIS JONATHAN CAO and Interim CFO | Sale | -36,979 | -20.41%144,240 | $37.12 | $1,372,668 | View SEC filing | |
| 2026-07-17 | Foff Erin Pennock Chief Medical Officer | Sale | -47,158 | -42.43%63,987 | $36.78 | $1,734,490 | View SEC filing | |
| 2026-07-17 | Hanson Kristopher General Counsel | Sale | -16,508 | -10.17%145,823 | $36.82 | $607,870 | View SEC filing | |
| 2026-07-17 | Lillie James Woodruff Chief Scientific Officer | Sale | -18,267 | -7.53%224,462 | $36.88 | $673,636 | View SEC filing | |
| 2026-07-17 | Kroeger Christopher A. Chief Executive Officer | Sale | -147,639 | -40.75%214,707 | $36.87 | $5,443,722 | View SEC filing | |
| 2026-05-18 | Kroeger Christopher A. Chief Executive Officer | Sale | -118,235 | -24.60%362,346 | $27.19 | $3,215,000 | View SEC filing | |
| 2026-05-11 | Foff Erin Pennock Chief Medical Officer | Sale | -4,438 | -3.84%111,145 | $28.54 | $126,640 | View SEC filing | |
| 2026-05-11 | Hanson Kristopher General Counsel | Sale | -13,917 | -7.90%162,331 | $30.13 | $419,263 | View SEC filing | |
| 2026-05-11 | Lillie James Woodruff Chief Scientific Officer | Sale | -721 | -0.30%242,729 | $28.28 | $20,390 | View SEC filing | |
| 2026-05-11 | Kroeger Christopher A. Chief Executive Officer | Sale | -68,491 | -12.47%480,581 | $28.47 | $1,949,634 | View SEC filing | |
| 2026-05-06 | Setia Vishwas Chief Financial Officer | Sale | -36,371 | -92.40%2,990 | $28.17 | $1,024,719 | View SEC filing | |
| 2026-05-06 | Foff Erin Pennock Chief Medical Officer | Sale | -50,280 | -30.31%115,583 | $28.39 | $1,427,594 | View SEC filing | |
| 2026-05-06 | Hanson Kristopher General Counsel | Sale | -13,917 | -7.32%176,248 | $27.89 | $388,177 | View SEC filing | |
| 2026-05-06 | Lillie James Woodruff Chief Scientific Officer | Sale | -51,707 | -17.52%243,450 | $28.40 | $1,468,251 | View SEC filing | |
| 2026-05-06 | Kroeger Christopher A. Chief Executive Officer | Sale | -49,744 | -8.31%549,072 | $28.39 | $1,412,236 | View SEC filing | |
| 2026-04-27 | Kreitzer Anatol Chief Discovery Officer | Sale | -45,422 | -17.70%211,190 | $29.66 | $1,347,066 | View SEC filing | |
| 2026-04-27 | GILLIS JONATHAN CAAO and PAO | Sale | -69,835 | -27.82%181,219 | $29.89 | $2,087,687 | View SEC filing | |
| 2026-04-17 | Setia Vishwas Chief Financial Officer | Sale | -2,922 | -0.74%392,627 | $26.89 | $78,572 | View SEC filing | |
| 2026-04-17 | Kreitzer Anatol Chief Discovery Officer | Sale | -3,316 | -1.28%256,612 | $26.61 | $88,239 | View SEC filing | |
| 2026-04-17 | Foff Erin Pennock Chief Medical Officer | Sale | -3,213 | -0.80%400,777 | $27.03 | $86,859 | View SEC filing | |
| 2026-04-17 | Malenka Robert C. Director | Sale | -8,593 | -2.41%348,138 | $26.90 | $231,152 | View SEC filing | |
| 2026-04-17 | Hanson Kristopher General Counsel | Sale | -1,827 | -0.95%190,165 | $26.89 | $49,134 | View SEC filing | |
| 2026-04-17 | Lillie James Woodruff Chief Scientific Officer | Sale | -4,513 | -1.51%295,157 | $27.16 | $122,574 | View SEC filing | |
| 2026-04-17 | GILLIS JONATHAN CAAO and PAO | Sale | -3,590 | -1.41%251,054 | $26.61 | $95,530 | View SEC filing |
1-25 of 35